{"schema_version":"secwatch.filing_event.v1","accession":"0001818382-25-000061","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2025-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.863107+00:00","generated_at":"2026-05-23T11:08:09.412663+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Humacyte CEO: citizen petition is baseless; signatories have conflicts of interest","bullets":["CEO Laura Niklason says petition signed by Robert E. Lee and Hooman Noorchashm is 'without merit'.","States Lee left FDA last fall and now heads Echelon, which advises Phraxis, a competitor.","Notes Noorchashm has filed nine prior FDA petitions with no resulting agency action.","Company will respond to the FDA at the appropriate time, calling claims 'false and harmful'."],"urls":{"canonical":"https://secwatch.observer/filing/0001818382-25-000061","json":"https://secwatch.observer/filing/0001818382-25-000061.json","markdown":"https://secwatch.observer/filing/0001818382-25-000061.md","text":"https://secwatch.observer/filing/0001818382-25-000061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000061/0001818382-25-000061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000181838225000061/huma-20250417.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T11:08:09.412663+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}